Patent details

EP3793517 Title: PHARMACEUTICAL FORMULATION

Basic Information

Publication number:
EP3793517
PCT Application Number:
EP2019062534
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP197283211
PCT Publication Number:
WO2019219773
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATION
French Title of Invention:
FORMULATION PHARMACEUTIQUE
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNG
SPC Number:

Dates

Filing date:
15/05/2019
Grant date:
19/04/2023
EP Publication Date:
24/03/2021
PCT Publication Date:
21/11/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/04/2023
EP B1 Publication Date:
19/04/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/05/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/04/2023
 
 

Name:
Klaria Pharma Holding AB
Address:
Virdings Allé 2, 754 50 Uppsala, Sweden (SE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/06/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SINGH, Shalini
Address:
Sweden (SE)

2

Name:
BOYER, Scott
Address:
Sweden (SE)

3

Name:
HÜBINETTE, Fredrik
Address:
Sweden (SE)

Priority

Priority Number:
201807942
Priority Date:
16/05/2018
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/00; A61K 9/70; A61K 47/36; A61K 31/352;

Publication

European Patent Bulletin

Issue number:
202316
Publication date:
19/04/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/04/2024
Last Annual Fee Paid Number:
6
Last Annual Fee Paid Amount:
66 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
29/06/2023 Power Of Attorney 1
30/06/2023 Outgoing Correspondence 1